Skip to Content

WATSON 3208 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint WATSON 3208 is Orange, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Watson Pharmaceuticals.

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3208

Rivastigmine tartrate 1.5 mg WATSON 3208
Rivastigmine tartrate 1.5 mg WATSON 3208
Rivastigmine tartrate 1.5 mg WATSON 3208

Rivastigmine Tartrate

Imprint
WATSON 3208
Strength
1.5 mg
Color
Orange
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, gelatin, titanium dioxide, ferric oxide yellow, ferric oxide red, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, shellac, propylene glycol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-3208 Watson Pharmaceuticals, Inc.
63739-0576 McKesson Packaging Services

Get help with Imprint Code FAQs.

Related Images for "WATSON 3208"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.